Brian Hill sells shares for estate planning, investment diversification and charitable giving purposes Remains Aritzia’s largest shareholder with approximately 15.9% equity interest NOT FOR DISTRIBUTION IN THE UNITED STATES
14 January 2026. Stockholm: Bitwise today announces the listing of seven of its crypto ETPs on Nasdaq Stockholm, marking a strategic expansion in the Nordic markets. The listings give Swedish investors access to exchange-listed crypto exposure through regulated products denominated in Swedish kronor (SEK). The company has appointed Marco Poblete as Regional Director for the…
LOS ANGELES, Jan. 14, 2026 (GLOBE NEWSWIRE) -- Evolutionary biologist Dr. Toby Kiers is receiving the Tyler Prize for Environmental Achievement, considered the ‘Nobel Prize for Environment’, as her not-for-profit, the Society for the Protection of Underground Networks (SPUN), launches a new program called “Underground Advocates” equipping scientists with legal tools to protect fungal biodiversity, the…
PHILADELPHIA and VANCOUVER, British Columbia, Jan. 13, 2026 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXL) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care, today announced the pricing of a best-efforts public offering of 5,366,726 units. Each unit consists of one common share (or…
BOSTON, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Block & Leviton is investigating Travere Therapeutics, Inc. (Nasdaq: TVTX) for potential securities law violations. Investors who have lost money in their Travere Therapeutics, Inc. investment should contact the firm to learn more about how they might recover those losses. For more details, visit https://blockleviton.com/cases/tvtx.
